Pharming Group N.V.
PHARM.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €637 | €934 | €1,025 | €679 |
| - Cash | €53 | €62 | €207 | €192 |
| + Debt | €108 | €172 | €167 | €162 |
| Enterprise Value | €693 | €1,043 | €985 | €649 |
| Revenue | €287 | €245 | €206 | €190 |
| % Growth | 16.9% | 19.3% | 8.3% | – |
| Gross Profit | €232 | €220 | €188 | €170 |
| % Margin | 80.8% | 89.7% | 91.5% | 89.4% |
| EBITDA | €13 | €10 | €34 | €49 |
| % Margin | 4.6% | 4% | 16.3% | 25.7% |
| Net Income | -€11 | -€11 | €14 | €16 |
| % Margin | -3.7% | -4.3% | 6.7% | 8.4% |
| EPS Diluted | -0.015 | -0.013 | 0.015 | 0.018 |
| % Growth | -20.3% | -184.2% | -17.4% | – |
| Operating Cash Flow | -€2 | -€17 | €23 | €36 |
| Capital Expenditures | -€1 | -€1 | -€2 | -€16 |
| Free Cash Flow | -€2 | -€19 | €21 | €20 |